180 Life Sciences Corp (ATNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Operating Expenses | 1,847 | 2,093 | 1,453 | 3,538 | 3,683 |
Operating Income | -1,847 | -2,093 | -1,453 | -3,538 | -3,683 |
Interest Expense | 11 | 16 | 10 | 12 | 12 |
Other Income | 1,870 | 1,039 | 231 | -9,061 | 14 |
Pre-tax Income | 12 | -1,070 | -1,232 | -12,611 | -3,680 |
Income Tax | N/A | N/A | -4 | -2,345 | N/A |
Net Income Continuous | 12 | -1,070 | -1,227 | -10,266 | -3,680 |
Net Income | $12 | $-1,070 | $-1,227 | $-10,266 | $-3,680 |
EPS Basic Total Ops | 0.01 | -1.68 | 9.45 | -24.52 | -13.37 |
EPS Basic Continuous Ops | 0.01 | -1.68 | 9.50 | -24.54 | -13.38 |
EPS Diluted Total Ops | 0.01 | -1.68 | 9.45 | -24.52 | -13.37 |
EPS Diluted Continuous Ops | 0.01 | -1.68 | 9.50 | -24.54 | -13.38 |
EPS Diluted Before Non-Recurring Items | 0.01 | -1.68 | N/A | -2.85 | -13.31 |
EBITDA(a) | $-1,800 | $-1,833 | $-928 | $-2,922 | $-3,103 |